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ABSTRACT 
 
Beta-catenin is a component of the intercalated disc in cardiomyocytes, but 
can also be involved in signalling and activation of gene transcription. We 
wanted to determine how long-term changes in beta-catenin expression levels 
would affect mature cardiomyocytes. 
Conditional transgenic mice that either lacked beta-catenin or that expressed 
a non-degradable form of beta-catenin in the adult ventricle were created. 
While mice lacking beta-catenin in the ventricle do not have an overt 
phenotype, mice expressing a non-degradable form develop dilated 
cardiomyopathy and do not survive beyond five months. A detailed analysis 
could reveal that this phenotype is correlated with a distinct localisation of 
beta-catenin in adult cardiomyocytes, which cannot be detected in the 
nucleus, no matter how much protein is present.  
Our report is the first study that addresses long-term effects of either the 
absence of beta-catenin or its stabilisation on ventricular cardiomyocytes and 
it suggests that beta-catenin’s role in the nucleus may be of little significance 
in the healthy adult heart. 
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INTRODUCTION 
 
Beta-catenin was initially characterised as an adherens junction protein (for 
review see e.g. [15]) and subsequently established as the central player of the 
canonical Wnt signalling pathway, which plays a major role in the 
development of cancer, particularly colon cancer [46]. In addition, beta-
catenin signalling seems to be crucial for the maintenance and expansion of 
different stem cell niches, not only in the gut but also e.g. in skeletal muscle 
[34]. During heart development beta-catenin seems to play a dual role: initially 
it is essential for mesoderm specification [17], however at later stages beta-
catenin signalling seems to affect cardiac mesoderm differentiation negatively 
[27]. Therefore beta-catenin seems to be a molecule that regulates 
proliferative behaviour rather than differentiation. This is difficult to reconcile 
with the fact that beta-catenin is highly expressed in adult cardiomyocytes, 
which are generally thought to be postmitotic. Beta-catenin is a major 
constituent of the intercalated disc, the specialised type of cell-cell contact in 
the heart, and its expression has been shown to be upregulated in dilated 
cardiomyopathy [35]. 
Since beta-catenin knockout mice die even before the formation of a heart 
[17], conditional knockout strategies were employed to study beta-catenin 
function. Several mouse strains have been generated using an inducible 
strategy in combination with the alpha-myosin heavy chain promoter and 
under these short-term conditions the lack of beta-catenin is well tolerated, 
partially due the upregulation of the expression of gamma-catenin 
(plakoglobin) [2, 5, 51]. However, embryonic lethality was observed when a 
non inducible alpha-myosin heavy chain promoter was used to drive Cre 
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expression [49], while heterozygous animals displayed neither a structural nor 
a functional phenotype at least under base line conditions [37]. 
Since the turnover of beta-catenin is regulated by phosphorylation by GSK3-
beta at its N-terminus, deletion of exon 3, which removes these serine and 
threonine residues creates a stabilised version of beta-catenin [20]. Inducible 
expression under the control of the alpha-myosin heavy chain promoter 
revealed a failure to undergo adaptive cardiac remodelling [2]. This is in 
contrast to observations by other groups, demonstrating that stabilisation of 
beta-catenin by different approaches positively affects hypertrophic growth of 
cardiomyocytes [5, 19]. In addition, it was shown that adenoviral-mediated 
overexpression of beta-catenin enhances the survival of cardiac cells 
following myocardial infarction due to the activation of anti-apoptotic pathways 
[18]. 
No study exists so far that would examine the effect of a long-term 
interference with beta-catenin expression levels on the heart. Therefore we 
created conditional knockout mice that carry a beta-catenin deletion 
specifically in the ventricular myocardium using the MLC2v-Cre strain [3, 4] 
and induced consistent over-expression of beta-catenin by crossing mice with 
floxed beta-catenin exon 3 with the MLC2v Cre strain [4, 20]. The careful 
phenotyping and subcellular analysis of both mouse strains shows that while 
the lack of beta-catenin at the intercalated disc is tolerable for heart structure, 
an excess of beta-catenin is detrimental and leads to dilated cardiomyopathy. 
Comparison of beta-catenin localisation in cardiac cells at different stages of 
differentiation showed that nuclear beta-catenin could only be detected in 
early embryonic cardiomyocytes and in the cardiac cell line HL-1. 
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We suggest that there is a strict control over the subcellular targeting of beta-
catenin in the environment of an adult heart muscle cell and that beta-
catenin’s nuclear role may not be relevant in this specific scenario. 
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MATERIAL AND METHODS 
 
Animal breeding and maintenance 
 
Transgenic knock-in mice expressing Cre recombinase under the control of 
the myosin light chain 2v promoter [4] were bred with beta-catenin floxed mice 
[3] to generate animals with a deletion of beta-catenin restricted to the 
ventricular myocardium (MLC2vCre/wt;beta-catenin flox/flox), referred to as cKO 
animals. In parallel, MLC2v-Cre mice were bred with beta-catenin exon 3 
floxed mice [20] to generate animals with a stabilisation of the protein 
(MLC2vCre/wt;beta-catenin exon 3 flox/flox) referred to as cex3 mice. Due to 
different parental lines the animals have a genetically mixed background. 
Maintenance and animal experimentation were in accordance with the Guide 
for the Care and Use of Laboratory Animals published by the US National 
Institutes of Health (NIH Publication No. 85-23, revised 1996) and followed 
Swiss Federal Veterinary Office (BVET) guidelines. Genotyping PCR for 
MLC2v Cre and floxed beta-catenin alleles were performed as described in 
the original publications [3, 4, 20]. 
 
 
SDS-PAGE and immunoblotting 
 
Preparation of heart samples, SDS-PAGE and immunoblotting were 
performed as described previously [21].  
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RNA analysis 
 
Total RNA was extracted from heart tissue with Trizol reagent (Invitrogen, 
Basel, Switzerland) followed by isopropanol precipitation. RNA was reverse-
transcribed with Thermoscript RT-PCR system kit (Invitrogen) according to 
the manufacturer’s instructions. PCR reactions were carried out in 50 l 
volumes with a set of gene specific primers. The amplification products were 
run on standard agarose gels, isolated and sequenced to ascertain accurate 
gene amplification. 
 
Isolation of adult cardiomyocytes 
 
After cannulation of the aorta, the heart was mounted on a Langendorf setup 
with a flow rate of 2 ml per minute. Tyrode's solution (137 mM NaCl, 5.4 mM 
KCl, 20.5 mM MgCl, 1.8 mM CaCl2, 11.8 mM Na-HEPES, 10 mM glucose; pH 
7.4) was used for washing out the blood. After this, the heart was perfused 
with calcium-free Tyrode (130 mM NaCl, 5.4 mM KCl, 1.2 mM KH2PO4, 1.2 
mM MgSO4, 6 mM Na-HEPES; pH 7.2) for about 6 minutes followed by 
perfusion with 0.1 mg/ml of Blendzyme 3 (Roche Diagnostics, Rotkreuz, 
Switzerland) dissolved in calcium-free Tyrode. This solution was recirculated 
for 12 minutes. After washing with calcium-free Tyrode supplemented with 
0.18 mM CaCl2 for about 15 minutes, the ventricles were removed, gently 
minced and agitated in a beaker until a cloudy cell suspension was obtained. 
Cells were allowed to settle and were washed twice with the same solution. 
After the isolation, 100 litres of cell suspension were immobilised on 
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gelatinised microscope slides by centrifugation at low speed with a Cytospin 
apparatus (Shandon Southern Inc, Pittsburgh, USA). Z-stacks of isolated 
immunostained cardiomyocytes were taken by confocal microscopy and 
volume rendering and volume calculation was made using the Surpass® 
module of Imaris (Bitplane AG).  
 
Cell culture and immunofluorescence 
 
HL-1 cells were a kind gift by Dr Katja Gehmlich (University College London) 
and were grown in Claycomb’s medium (Sigma) that was supplemented with 
10% fetal cal serum (Sigma), 2mM glutamine, 100 units/g/ml 
penicillin/streptomycin and 100 M noradrenalin (Sigma). Neonatal rat 
cardiomyocytes were isolated using the Neonatal Cardiomyocyte Isolation 
System from Worthington (Lakewood, NJ, USA) and maintained as mentioned 
previously (19). Embryonic mouse heart whole mount preparations and 
cryosections were prepared as described previously [21]. Isolated 
cardiomyocytes were fixed for 10 minutes with 4% PFA, permeabilised by 
incubation with 0.2% Triton X-100 for 10 min and immunofluorescence 
reactions, mounting of specimens and confocal microscopy using a 
63x/1.32NA oil immersion lens were performed as described previously [21]. 
 
Subcellular fractionation 
 
Subcellular fractionation was performed on cultured cells and on mouse 
ventricles as described [23]. Sodium butyrate (SB) was added at a 
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concentration of 5mM for 12 hours to the cultured cells, while LiCl (10 mM and 
20 mM) was added 30 minutes before harvesting the cells. Confluent cells 
and heart ventricles were washed twice with ice-cold PBS and then disrupted 
using a Polytron apparatus in 5 ml of buffer B (10 mM HEPES pH 7.4, 5 mM 
EDTA), supplemented with 0.32 M sucrose and a protease inhibitor cocktail 
(Roche Diagnostics). Whole heart homogenate was filtered through 4 layers 
of cheesecloth to remove large cellular debris. Samples were then centrifuged 
at 3’800 g for 20 minutes. The supernatant fraction (S1) was clarified by 
centrifugation at 10’000 g for 20 minutes before centrifugation at 100’000 g for 
1 hour. The resulting pellet (P2 fraction) containing the membrane fraction 
was resuspended in 200 l of buffer B. The initial 3’800 g pellet (P1) was 
resuspended in 4 ml of buffer B containing 2.4M sucrose. Nuclei were 
sedimented by centrifugation at 50’000 g for 90 minutes. The nuclei 
containing pellet was resuspended in 1 ml of buffer B with 0.32 M sucrose and 
centrifuged at 3’800 g. The final pellet was resuspended in 50 l of buffer B. 
The membrane and nuclear fraction were then mixed 1:1 with SDS sample 
buffer and separated on SDS-PAGE as described above. 
 
Antibodies 
 
The monoclonal mouse (mM) anti-sarcomeric alpha-actinin (clone E53), anti-
vinculin (hVin-1), the polyclonal rabbit (pR) anti-pan-cadherin, anti-beta-
catenin, anti-alphaE-catenin, anti-laminin and anti-all actin antibodies were 
from Sigma. The mM anti beta-catenin (c14), anti-beta1-integrin (c18), anti-
plakoglobin (c15) antibodies were purchased from Pharmingen (BD 
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Biosciences, Allschwil, Switzerland). The mM anti-desmin (D33) was from 
DAKO (Glostrup, Denmark). The mM anti-alpha-cardiac actin (Ac1-20.4.2) 
was from Progen (Progen Biotechnik, Heidelberg, Germany). The pR anti-
desmoplakin antibody was purchased from Serotec (Oxford, UK). The pR 
anti-connexin 43 was obtained from Zymed (P.H Stehlin & Co. AG, Basel, 
Switzerland). The polyclonal goat anti LaminA was from Santa Cruz 
Biotechnology (Santa Cruz, USA). The pR anti N-RAP was a kind gift from 
Prof. R. Horowits (National Institutes of Health, Bethesda, USA) The pR anti-
MyBP-C antibody was a kind gift from Prof. M. Gautel (King’s College, 
London, UK). 
For immunofluorescence stainings, combination of FITC/Cy2, Cy3 and Cy5 
conjugated secondary antibodies were used as described previously (19) 
together with DAPI and Alexa 488/633 phalloidin (Invitrogen) for the staining 
of nuclei and actin filaments. HRP-conjugated anti-mouse Igs (DAKO, Zug, 
Switzerland) and anti-rabbit Igs (Calbiochem, Lucerne, Switzerland) were 
used for immunoblotting. 
 
Statistical analysis 
 
All statistical analyses and tests were carried out using Excel software 
(Microsoft, Redmond, USA). Data are given as mean +/- standard deviation. 
Bars in graphs represent standard errors and significance was assed by two-
tailed T test with a P value below 0.05. 
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RESULTS 
 
Generation of ventricle specific deletion and stabilisation of beta-catenin 
 
We used the Cre-lox technology to inactivate or stabilise the beta-catenin 
gene specifically in ventricular cardiomyocytes. Deletion of beta-catenin 
(referred to as cKO) was achieved by mating the MLC2v-Cre heterozygous 
strain [4] with beta-cateninflox/flox mice [3], while stabilisation (referred to as 
cex3) was by crossing heterozygous MLC2v-Cre with beta-catenin exon 
3flox/flox animals, which removes 76 amino acids from the N-terminus that 
contain the four phosphorylation sites, which target beta-catenin for 
degradation [20]. In both cases offspring with the expected Mendelian 
frequencies were observed at birth. However, while the cKO animals have a 
normal life span, all cex3 mice die of heart failure between 2.5 and 4.5 
months. Determination of the cardiac index revealed that cex3 animals 
developed dramatic cardiac hypertrophy at 2 and 4 months (Figure 1, black 
columns), whereas cKO animals had a similar HW/BW ratio as controls 
(Figure 1; see Table 1 for details). 
In order to find out, how fast and efficient the deletion of beta-catenin happens 
in ventricular cardiomyocytes, we stained frozen sections from cKO animals at 
postnatal day 3 (P3), 1, 2, 6 and 15 months with antibodies against beta-
catenin (Supplementary Figure 1). At P3 and 1 month no dramatic difference 
between WT and cKO animals was observed in the intensity and localisation 
of the beta-catenin signal. By 2 months the signal for beta-catenin 
disappeared in the ventricles, indicating that MLC2v Cre leads to efficient 
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recombination only postnatally and that beta-catenin, once it is integrated at 
the intercalated disc, may have a remarkable long half-life. 
 
Characterisation of the histological and cellular phenotype of cKO and cex3 
hearts 
 
To characterise the phenotype of beta-catenin cKO and cex3 ventricles, we 
initially performed hematoxilin-eosin stainings on whole heart cross-sections 
taken from comparable levels at 4 months of age (Figure 2 A-C). The hearts 
of cKO animals look similar to WT, however, the hearts from cex3 animals 
display a phenotype of dilated cardiomyopathy. Immunohistochemistry on 
frozen sections at two months, using two different antibodies against beta-
catenin, showed the expected reduction in signal in the cKO and a more 
intensive staining of the intercalated discs in the cex3 hearts. No nuclear 
signal could be observed with either beta-catenin antibody as demonstrated 
by the lack of colocalisation with DAPI (Figure 2F and data not shown). The 
general cytoarchitecture appears to be little affected in either beta-catenin 
strain since the myofibrils appear normal, when visualised with alpha-actinin 
staining for the Z-discs and F-actin staining with phalloidin. However, 
longitudinally cut cardiomyocytes in cex3 ventricles appear to have an 
increased diameter compared to WT or cKO, as delineated by the lateral 
laminin staining (green signal in Figure 2G, H, I). The overall structural 
alignment of the myocytes does not seem to be changed though, unlike in 
other cases of ventricular dilation for example after myocardial infarction [11].  
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To investigate effects on cell size and structure further, we prepared freshly 
isolated cardiomyocytes from cKO, WT and cex3 mice for immunostainings 
and volume measurements (Figure 3). The organisation of different 
components of the sarcomere is indistinguishable between the different beta-
catenin animals when we stained for MyBP-C, alpha-cardiac actin and 
desmin, despite the clear lack of beta-catenin in intercalated discs of cKO 
cardiomyocytes and the increased signal compared to controls in cex3 
cardiomyocytes (green signal in Figure 3 A-F). Volume projections revealed 
that cKO cardiomyocytes have a slightly more irregular shape than WT at 4 
months, while the majority of cex3 cardiomyocytes are dramatically larger. 
Cell volume measurements showed that while WT and cKO cardiomyocytes 
display a narrow Gaussian distribution of their volumes, while cex3 
cardiomyocytes show a wide distribution of sizes (Figure 3G; for detailed size 
measurements see Supplementary Table 1). The sizes are in good 
agreement with previously determined cell sizes in adult mouse hearts and a 
lack of strict size control was also seen in a well-known mouse model for 
DCM, the MLP knockout mouse [26]. Comparison of cardiomyocyte 
populations from cex3 animals revealed that the dramatic increase in size 
always goes hand in hand with increased beta-catenin signal at the 
intercalated disc, indicating successful Cre lox recombination. A subset of 
cardiomyocytes display normal sizes and normal intensities of beta-catenin 
signal, probably representing untargeted cells (left cell in Figure 3H). Again no 
beta-catenin signal could be detected in the nucleus of cex3 cardiomyocytes 
(Figure 3H). 
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Is intercalated disc composition affected in cKO or cex3 ventricles? 
 
The lack of phenotype in inducible conditional beta-catenin knockout mice 
may be explained by an upregulation of gamma-catenin (plakoglobin) [51]. To 
check for alterations in the expression levels of different intercalated disk 
proteins in our stable conditionally beta-catenin deleted or overexpressing 
animals, we performed immunoblots on ventricular samples from 2 months 
(WT, cKO and cex3) and 6 months old mice (WT, cKO; Figure 4). The 
downregulation of beta-catenin expression in ventricular samples of cKO mice 
compared to controls is already clearly visible at 2 months. A slight 
upregulation in expression could be seen in the case of alphaE-catenin and 
plakoglobin in cKO animals, but no changes were apparent for desmoplakin, 
beta1-integrin, cadherins, vinculin or connexin-43 (Figure 4A, for 
densitometric quantifications see Supplementary Table 2). Confocal 
microscopy of intercalated disc structure on immunostained frozen sections 
also showed no alterations in the localisation of cadherin, desmoplakin or 
connexin-43 in cKO compared to WT (Supplementary Figure 2). Analysis of 
cex3 ventricles revealed a downregulation of the wildtype form of beta-
catenin with a concomitant expression of the truncated, stabilised from (Figure 
4B). The signal for the residual wildtype beta-catenin is derived from non-
cardiomyocytes, since whole ventricular muscle extracts were used and from 
the few cardiomyocytes in which Cre recombination has not yet happened. No 
changes in expression levels were seen for desmoplakin, cadherins, alphaE-
catenin, plakoglobin or connexin-43. A dramatic increase was observed for N-
RAP, a LIM domain containing protein of the intercalated disc in samples from 
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cex3 mice. This probably reflects the DCM phenotype of these animals, 
since the upregulation of N-RAP was shown previously to be an early marker 
for DCM [8]. 
To characterise the phenotype of ventricles lacking or stably expressing beta-
catenin more closely, we analysed the expression of well-known markers of 
hypertrophy by RT-PCR (Figure 5). In samples from cex3 ventricles all 
markers such as ANF, BNP, alpha-skeletal actin and beta-myosin heavy 
chain displayed upregulation of expression. No significant upregulation was 
found for cKO samples. Beta-catenin stabilisation had no effect on the 
expression of genes that are known downstream targets of Wnt/beta-catenin 
signalling, since no significant change could be observed in connexin-43, 
cyclin D1 and c-myc expression in cex3 ventricles (Figure 5 and data not 
shown). The slight increase in fibronectin is due to increased fibrosis in the 
cex3 hearts as demonstrated by immunofluorescence on heart sections 
(data not shown and increased signal for laminin e.g. in Figure 2I top right). 
This again suggests that nuclear beta-catenin signalling is not activated in the 
cex3 cardiomyocytes.  
 
Can beta-catenin ever be detected in the nucleus of a cardiomyocyte? 
 
To unequivocally demonstrate the lack of nuclear beta-catenin in cex3 
ventricular cardiomyocytes we performed subcellular fractionation 
experiments (Figure 6). Membrane and nuclear fractions were tested for 
cross-contamination by the presence or absence of cadherin or lamin in the 
respective fractions by immunoblotting. In both cKO and cex3 membrane 
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samples a downregulation of wildtype beta-catenin is apparent, which is 
accompanied by the appearance of the smaller stabilsed beta-catenin protein 
in cex3 samples (Figure 6A). No beta-catenin could be observed in any of 
the nuclear ventricle fractions (Figure 6B). As a positive control, we used LiCl 
stimulated mouse embryonic fibroblasts (MEFs) and HCT116 cells, where a 
clear band for beta-catenin could be observed in the nuclear fractions. 
Sodium butyrate (SB) treatment stabilises beta-catenin at the cell membrane 
and therefore no nuclear beta-catenin signal is found [47]. 
We were concerned that the lack of nuclear signal in cex3 ventricular 
cardiomyocytes could be due to a staining artefact, since we would have 
expected some nuclear beta-catenin at least in a subset of the cells by 
immunofluorescence. The detection of several cytoskeletal proteins that 
translocate to the nucleus can require specific fixation conditions [32]. 
Confocal microscopy revealed that we can detect nuclear beta-catenin with 
our fixation and staining conditions, but only in HL-1 cells [6] (Figure 7a). HL-1 
cells represent a much more immature cardiac phenotype as demonstrated by 
the staining for the Z-disc protein alpha-actinin, which is only found in 
premyofibril-like arrangements [38] in these cells and not in proper cross-
striated myofibrils like in neonatal rat cardiomyocytes (NRC; Figure 7a). The 
observed signal is not due to nuclear background since no nuclear signal was 
detected with cadherin or alpha-catenin antibodies in either cell type and also 
nuclei in NRC were negative for beta-catenin. Also attempts to enrich for 
nuclear beta-catenin using lithium chloride stimulation and treatment with 
leptomycin B to prevent nuclear export failed to reveal significant nuclear 
signal in NRC (Supplementary Figure 3). We conclude that nuclear beta-
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catenin is a phenomenon that is only observed in embryonic or less well 
differentiated cardiomyocytes such as the HL-1 cells. Comparison of the 
relative expression levels of cadherin, alpha-catenin and beta-catenin in NRC 
and HL-1 cells suggest that the dramatically increased expression of alpha-
catenin may be responsible for the rapid targeting of beta-catenin to the cell-
cell contacts in mature cardiomyocytes (Figure 7b). It was shown previously 
that the availability of alpha-catenin affects whether beta-catenin is in a 
molecular form that can be targeted to the nucleus or not [14]. 
Since these results suggest a developmental and differentiation stage specific 
nuclear targeting of beta-catenin, we also looked at the localisation of beta-
catenin in embryonic mouse whole mount heart preparations obtained at 
embryonic day 9 (Figure 7c). While beta-catenin targets to nuclear subregions 
at this developmental stage in cardiomyocytes (arrows in Figure 7c), no 
nuclear signal is seen for its close relative plakoglobin at the same 
developmental stage. However, when neonatal mouse cardiomyocytes were 
analysed for beta-catenin in the nucleus, absolutely no signal could be 
detected outside of the intercalated disc [35]. 
In conclusion, while the long-term absence of ventricular beta-catenin is well 
tolerated in the heart, its stabilisation and concentration at the intercalated 
disc leads to a dramatic DCM phenotype with the expression of hypertrophic 
markers and lethality by 5 months. However, this phenotype is not due to 
increased nuclear beta-catenin in the cardiomyocytes at adult stages and 
must be caused by the activation of distinct signalling pathways. 
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DISCUSSION 
 
Aim of our study was to investigate the effects of long-term absence or 
stabilisation of beta-catenin in the heart. Postnatal deletion of beta-catenin in 
the ventricle has little effect on cardiac structure and function, while long-term 
expression of a stabilised form of beta-catenin leads to a phenotype of dilated 
cardiomyopathy with premature death, despite a lack of beta-catenin in the 
nucleus. No activation of gene expression of well-known beta-catenin target 
genes such as connexin-43 or cyclin D1 is detected. These data suggest that 
the observed phenotype is not due to the untimely activation of beta-catenin 
signalling, at least not nuclear signalling in the mature heart. This is in good 
agreement with published data on Wnt reporter animals, where the left 
ventricle tends to be negative [7, 22, 30, 33]. Wnt signalling is detected in 
cardiomyocyte populations that arose from the secondary heart field and also 
in cardiac precursor/stem cells [28]. These observations suggest that 
canonical Wnt signalling via beta-catenin plays no or little role in the healthy 
ventricular myocardium. Nuclear beta-catenin in adult cardiomyocytes was 
only convincingly demonstrated following adenovirus mediated gene transfer 
of a constitutively active, non-degradable beta-catenin into the heart [18]. In 
most other cases only indirect readouts of the presence of beta-catenin in the 
nucleus were taken by fractionation studies of entire heart tissue or by 
analysis of the activation of downstream target genes, again not using a 
purified cardiomyocyte population [2, 5]. Recent work by the Engelhardt 
laboratory has once more pointed out that deductions from whole heart tissue 
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can be slightly misleading since it may actually be signalling events in cardiac 
fibroblasts that lead to a particular readout in the entire tissue [44]. 
One potential explanation for the lack of nuclear beta-catenin in the 
cardiomyocytes in our cex3 animals could be that the deletion of the N-
terminus in the stabilised version also removes ubiquitinylation sites that may 
be relevant for subcellular targeting as shown for e.g. PTEN [45]. However, 
beta-catenin deletion studies showed that nuclear targeting is mediated by the 
C-terminus [25]. Nuclear import of beta-catenin requires the interaction with 
nuclear pore complexes [9] and recently beta-catenin was shown to interact 
with the nuclear lamina protein emerin [31], which can also be located at the 
outer nuclear membrane [39]. Emerin and beta-catenin also interact in the 
heart, where they colocalise at the intercalated disc [48]. Our results show 
that nuclear beta-catenin is a differentiation stage specific phenomenon in 
cardiomyocytes and not seen in the healthy adult myocardium, no matter how 
much beta-catenin would be available in the cells. This specific targeting can 
be partially explained by the high expression levels of alphaE-catenin in 
cardiomyocytes, which is decisive for the subcellular targeting of beta-catenin 
in other cell types [14]. Recently it was shown that beta-catenin turnover is 
also regulated by PP2A, which rapidly dephosphorylates the protein and 
prevents proteasomal degradation [43]. PP2A is highly expressed in the heart 
and can also be found at the intercalated disc in cardiomyocytes [42]. This 
presents another explanation for the extraordinary stability of beta-catenin in 
this cell type, taking two months to be cleared from cKO ventricles. 
In a previously published inducible beta-catenin targeted mouse strain the 
lack of cardiac phenotype was explained by an upregulation in expression 
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levels of plakoglobin (gamma-catenin; [51]). Plakoglobin was shown to act as 
a counterplayer of nuclear beta-catenin and to suppress canonical Wnt 
signalling in arrhythmogenic right ventricular cardiomyopathy [12]. However, 
again this activity seems to be more restricted to islet-positive cardiac 
progenitor cells originating from the second heart field [29]. Neither the group 
of Gerdes nor we were able to see nuclear plakoglobin in any of our beta-
catenin strains ([51], data not shown).  
Mice homozygous for a conditional deletion of beta-catenin using the alpha-
myosin heavy chain promoter to drive Cre expression do not survive beyond 
embryonic day 14.5 [37]. This is in contrast to our cKO mice, where the 
MLC2v promoter was used and where a normal life-span was observed. The 
most likely explanation for this difference is that since the MLC2v Cre only 
leads to postnatal recombination as shown previously in other mouse strains 
[40, 41, 50], the cardiac cytoarchitecture is well enough established to tolerate 
the deletion of beta-catenin by then. Interestingly the beta-catenin cKO mice 
are one of the few mouse strains that bear a conditional deletion of an 
intercalated disc protein that do not develop dilated cardiomyopathy. For 
example conditional knockout mice for beta1-integrin, vinculin and alphaE-
catenin all display severe DCM by about six months [40, 41, 50]. The 
deletions are often accompanied by changes in the expression levels of other 
intercalated disc proteins, with beta1-integrin and cadherin being 
downregulated in conditional vinculin knockout mice and vinculin 
downregulated and beta-catenin upregulated in conditional alphaE-catenin 
knockout mice [41, 50]. This upregulation of beta-catenin expression, which is 
accompanied by a higher degree of membrane convolution is also typical for 
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other mouse models of DCM [8]. It is therefore striking that the elevated 
expression levels of beta-catenin in our cex3 animals is sufficient to lead to a 
dramatic phenotype of DCM. The only other intercalated disc protein that is 
changed in its expression level in the cex3 animals is N-RAP, a LIM domain 
containing protein at the intercalated disc, which we have previously identified 
as one of the first marker proteins to become upregulated during the 
establishment of DCM [8]. Taken together these results suggest that the fine 
balance of protein composition at the intercalated disc, which takes until 
adolescence to establish [1, 21] only tolerates interference with expression 
levels to a certain extent and responds with a DCM phenotype if the balance 
is perturbed [35]. The extremely convoluted plasma membranes at the 
intercalated disc that accompany the DCM phenotype are reminiscent of 
intercalated discs in aged animals [10] and may indicate an inability to cope 
with mechanical stress, which is also increased due to the alterations in cell 
shape that are seen. Currently the signalling pathways that relay mechanical 
stress in cardiomyocytes and result in an altered cellular phenotype are far 
from well defined. MLP, which has been implicated to sense mechanical 
stress at the Z-disc [24] may be less a stress sensor rather than a stress 
transmitter due to its diffuse cytoplasmic localisation, which also includes the 
intercalated disc [13]. The severity of symptoms of DCM in patients is highly 
variable even in the case of hereditary DCM with mutations in the same gene 
(e.g. laminA/C [36]). Since also an extremely heterogeneous onset of the 
DCM phenotype is observed in human patients with hereditary DCM [16], our 
cex3 animals with their extremely reproducible case history may provide an 
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ideal tool to investigate the signalling pathways that lead to the establishment 
of a DCM phenotype more closely. 
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Figure Legends 
 
Figure 1: Comparison of the cardiac index of cKO and cex3 mice 
during postnatal development. While at one month the cardiac index shows 
no significant differences between different strains, it is increased to 8.9 and 
9.2 at two and four months in cex3 mice. At six months no viable cex3 
animals remained. *) P< 0.01; n.d. not done; n.a. not available. 
 
Figure 2: Histological analysis at four months and 
immunohistochemistry at two months show heart dilation and increased 
thickness of cardiomyocytes in cex3 animals. Cryosections of cKO (A, D, 
G), WT controls (B, E, H) and cex3 (C, F, I) hearts were stained with 
Hematoxilin-Eosin (A, B, C). Immunolabeling with two different antibodies 
against beta-catenin, a rabbit polyclonal (green signal in D, E, F) and a mouse 
monoclonal (red signal in G, H, I) showed lack of beta-catenin expression in 
the case of the cKO ventricles and increased signal at the intercalated discs in 
cex3 mice. Sections were counterstained with antibodies against alpha-
actinin (red signal in D, E, F) and DAPI (blue signal in D, E, F) or with 
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antibodies against laminin (green signal in G, H, I) and phalloidin to visualise 
F-actin (blue signal in G, H, I). Bar in A equals 1 mm, bar in D equals 30 
micrometres. 
 
Figure 3: Analysis of freshly isolated cardiomyocytes demonstrates the 
dramatic volume increase in a subset of cex3 cardiomyocytes. A-F) 
Freshly isolated cardiomyocytes of cKO (A-A’’, B), WT (C-C’’, D) and cex3 
(E-E’’, F, H) mice were stained for beta-catenin (green signal) together with 
myosin binding protein-C (red signal in A, C, E), alpha-cardiac actin (cA; red 
signal in A’, C’, E’), desmin (A’’, C’’, E’’) or F-actin (B, D, F, H), the nuclei in H 
were visualised with DAPI (blue signal). 3D reconstructions of representative 
cardiomyocytes (B, D, F; left cell at 2 months, right cell at 6 months in B and 
D, F is at 2 months; xy and xz projections, respectively) show a slight 
alteration in cell shape in cKO compared to WT, which is even more 
pronounced in the cex3. 
G) cKO and WT cells have a Gaussian distribution around a mean volume of 
25,890 and 21,840 micrometres3. In comparison, cex3 cells show a much 
wider, randomised distribution around a mean of 50,520 micrometres3. H) 
Two cells from a single cex3 animal with comparatively low levels of beta-
catenin (left cell) and a normal volume or a dramatic increase in beta-catenin 
combined with increased volume but still lacking nuclear beta-catenin (right 
cell). At least 30 cardiomyocytes were analysed per animal. Bar in A’’ and B 
equals 20 micrometers, bar in H equals 30 micrometres. 
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Figure 4: Expression of different intercalated disc associated proteins in 
cKO versus cex3 mice shown by immunoblotting of ventricular 
samples. A) Immunoblots of intercalated disc proteins in cKO and WT 
animals at two and six months (3 animals each). While beta-catenin levels are 
decreased to an equal extent at both stages, alphaE-catenin and plakoglobin 
show a slight upregulation only at six months. The levels of desmoplakin, 
connexin-43, beta1-integrin, cadherin and vinculin are unaffected. B) The 
stabilisation of beta-catenin after removal of exon 3 is clearly visible at two 
months (lower band) while at the same time the WT isoform levels are 
decreased (upper band). Cadherins, alphaE-catenin and plakoglobin as well 
as desmoplakin and connexin-43 show unchanged expression levels, N-RAP 
is dramatically increased. Actin (all isoforms) was used as a loading control in 
both cases. 
 
Figure 5: The increased cardiac index in cex3 mice is accompanied by 
the expression of hypertrophy markers. Semi-quantitative RT-PCR 
analysis of total RNA isolated from WT, cex3, cKO and MLP knockout mice 
show that cex3 hearts but not cKO show an upregulation of hypertrophy 
markers such as ANF, BNP, alpha-skeletal actin and beta-myosin heavy 
chain similar to the positive control, the MLP knockout mouse. Analysis of 
Wnt/beta-catenin responding genes such as fibronectin and connexin-43 did 
not show increased expression in the cex3 ventricles. Expression of alpha-
cardiac actin and GAPDH was used as internal control, the last row (-RT) is 
the negative control. 
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Figure 6: Fractionation experiments demonstrate the absence of nuclear 
beta-catenin in the cex3 ventricles. Subcellular fractionation was 
performed with mouse embryonic fibroblasts (MEF) under different growth 
conditions, HCT116 (colon carcinoma) cells and ventricles of WT, cKO and 
cex3 mice and followed by immunoblotting. A) Membrane fraction shows 
decreased beta-catenin (WT) levels in both the cKO and the cex3 ventricles 
and the stabilised shorter beta-catenin form. B) Nuclear fraction shows beta-
catenin in MEF cells following LiCl treatment and in HCT116 cells but no 
signal in cex3 samples. Cadherin and lamin antibodies demonstrate the 
absence of cross-contamination. The two lanes to the right show total lysates 
to indicate the expected molecular weight of the proteins that were analysed. 
 
Figure 7: Nuclear targeting of beta-catenin in cardiomyocytes is 
differentiation stage specific. a) Confocal micrographs of neonatal rat 
cardiomyocytes (NRC, A-F) and HL-1 cells (A’-F’) stained with antibodies 
against cadherin (B, B’), alpha-catenin (D, D’) and beta-catenin (F, F’) and 
alpha-actinin (A, C, E, A’, C’, E’). While the adherens junction proteins are 
exclusively found at intercalated disc-like structures in NRC, beta-catenin 
additionally shows nuclear localisation in HL-1 cells. b) An immunoblot shows 
increased expression of alpha-catenin in NRC compared to HL-1 cells, while 
cadherin and beta-catenin seem to be expressed at equal levels. c) Emryonic 
day 9 mouse whole mount heart preparations stained for alpha-actinin (first 
column, beta-catenin and plakoglobin, respectively (second column), DAPI to 
visualise the nuclei (third column); the fourth column shows the overlay. Beta-
catenin targets to nuclear subregions at this stage (arrows), but is absent from 
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condensed chromosomes in dividing cardiomyocytes. Plakoglobin is almost 
exclusively localised to the cell-cell contacts with only faint cytoplasmic but 
never any nuclear signal. 
Supplementary Figure 1: Beta-catenin protein only becomes fully absent 
in the ventricle after two months. Confocal micrographs of frozen sections 
stained with monoclonal mouse anti beta-catenin from WT (left column) and 
cKO (right column) mice at postnatal day 3 (P3), one month, two months, six 
months and fifteen months of age. The beta-catenin signal at P3 and one 
month is comparable between WT and cKO and only disappears at two 
months, indicating a slow turnover of the protein at the intercalated disc. Bar 
in A equals 10 micometres, bar in C equals 20 micrometres. 
 
Supplementary Figure 2: Intercalated disc organisation is hardly affected 
by the absence of beta-catenin. Confocal micrographs of frozen sections of 
two months old WT (A, B, E, F, I, J) and cKO ventricles (C, D, G, H, K, L) 
immunostained for cadherins (A, C), beta-catenin (B, D, F, H, J, L), 
desmoplakin (E, G) and connexin-43 (I, K). Cadherin staining is slightly more 
pronounced in the cKO (compare C with A), however neither desmosomes 
nor gap junctions seem to be altered. Occasional residual beta-catenin 
containing intercalated discs indicate a lack of recombination (arrow in H). Bar 
equals 20 micrometres. 
 
Supplementary Figure 3: Nuclear accumulation of beta-catenin following 
lithium chloride stimulation and inhibition of nuclear export by 
leptomycin B can be detected in HL-1 cells but not in NRC. Confocal 
micrographs of HL-1 cells (top two rows) and NRC (bottom two rows) stained 
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for beta-catenin and with DAPI to visualise nuclei. Cells were grown either in 
control medium, in medium supplemented with lithium chloride (LiCl), 
leptomycin B (LMB) or both. Bar equals 10 micrometres. 
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Table 1: Echocardiographic data and cardiac index 
 cKO measurements cex3 measurements 
 WT § 
-catenin 
cKO § 
WT § 
-catenin 
cex3 § 
LVAWD, mm 1.46±0.10 1.45±0.13 1.52±0.11 1.08±0.11* 
LVAWS, mm 1.68±0.06 1.77±0.23 1.95±0.10 1.22±0.10* 
LVD, mm 3.07±0.11 3.04±0.17 3.38±±0.11 5.43±0.25* 
LVS, mm 1.64±0.24 1.60±0.25 1.52±0.06 4.58±0.12* 
IVSD, mm 0.28±0.05 0.31±0.03 0.30±0.00 0.28±0.20 
IVSS, mm 0.35±0.05 0.39±0.07 0.47±0.07 0.32±0.20 
Fractional shortening, % 46.8±6.3 47.4±7.2 55.2±1.1 15.1±5.7* 
Cardiac index, mg heart/g 
body weight 
4.90±0.34 4.61±0.42 4.77±0.20 8.75±0.55* 
* P< 0.05 compared with WT 
mice 
 
§) n=8 mice (9-10 weeks old at the beginning of the experiment) in each group with the exception of -catenin cex3 where n=6. 
 
LVAW(D/S): left ventricle anterior wall thickness (at diastole/systole) 
LV(D/S): left ventricle (diastolic/systolic) diameter 
IVS(D/S): intra-ventricular septum thickness (at diastole/systole) 
 
Fractional shortening: [(LVD-LVS)/LVD]x100 
Values are mean ±SD 
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